RE:RE:Shure hope they avoid another OO at these levelsI would need to know quite a bit more before committing to additional investment and deciding on what was a reasonable price under whatever circumstances the company is actually in at the time. I would need to spend time with Christian to get answers to quite a few questions and would need to know what plan A is (if TH-1902 works) and plan B (if it doesn't), at a minimum. My hope is they can keep things together financially until such time as they know if they will be pursuing Plan A or Plan B. If they can't do that, it will not be a good situation. If they can, then they it should be a lot easier to pull off in a non-disastrous way. If Plan A come to fruition, obviously, a higher price on any offering would be justified withthe actual price determined bythe strength of the results. If instead, Plan B is unfortunatly needed, then we would all need a really good and believable budget to determine what price would be fair, but it is hard to see a ton of interest in the stock if all it offers is th two legacy drugs.
Also, I mentioned the financing OMER did where they sold future revenues of their drug at a discount to raise cash. It might be something THTX should consider if their confidence is high that TH-1902 is going to work.
Wino115 wrote: Let's poll folks. At what price and amount would you be ok with them taking down some ATM at?
Let's make these assumptions: Take down next Marathon round and pay off full convert. Hit EBITDA breakeven at FY end.
How much and at what price is satisfactory to you?